Due to their micron size, MBs are intra-vascular agents; therefore actively targeting tumor endothelial markers (such as VEGFR2 or αvβ3 integrin) have been used to enhance the imaging of tumor vasculature 29-31 and also to target liposomes 10, 11, 32. Here, KDR is linked to neoplasm.